Clinical Trial

A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors

Name: A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors — clinical trial record (NCT07050459)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0686 in Adult Participants with Locally Advanced/Metastatic Solid Tumors

Trial Details

NCT Number	NCT07050459
Lead Sponsor	Jiangsu Simcere Pharmaceutical Co., Ltd.
Conditions	Locally Advanced Solid Tumors
Enrollment	220 participants
Start Date	2025-05-20
Primary Completion	2027-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2025-07-03